Does anti-reflux surgery control Barrett’s oesophagus progression?


  • Ali J. Alghazzawi Department of Surgery, Macquarie University Hospital, Sydney, NSW, Australia
  • Ali A. Khabaza Department of Radiology, Royal Prince Alfred Hospital, Sydney, NSW, Australia
  • Mohammed H. Al-Hijaji Department of Surgery, Macquarie University Hospital, Sydney, NSW, Australia



Anti-reflux surgery, Barrett's oesophagus, Outcome


Controversy exists as to whether or not anti-reflux surgery can prevent the potential long-term complications of Barrett's oesophagus, in particular, dysplastic changes. Hence, literature was reviewed to find out effects of anti-reflux surgery on patients with Barrett's oesophagus. Data has been analysed using different electronic database including Ovid Medline, Scopus, Google Scholar and PubMed. Anti-reflux surgery is considered an effective option for rapid and long-term control of reflux symptoms. Most patients who were included in the studies had a satisfactory control of their symptoms after surgery. Successful procedures effectively abolished gastric reflux in the majority of patients. On the other hand, there were different patterns of Barrett's oesophagus segment progression after surgery regardless of the procedure's success. Many patients developed de novo Barrett's oesophagus, at the same time the intestinal metaplasia regressed in other patients, but the Barrett segment has remained unchanged in the majority of patients. Similarly, the pattern of dysplasia progression was different among patients. Surgery was effective in producing dysplasia regression in many patients, but it failed to prevent progression of columnar intestinal metaplasia into dysplasia in other patients.  In conclusion the potential long-term complications of Barrett's oesophagus can develop after anti-reflux surgery. Therefore, long life follow- up, after surgery, is mandatory.


Barrett NR: Chronic peptic ulcer of the esophagus and esophagitis. Br J Surg. 1950;38(150):175-82.

Sampliner RE. Practice guidelines on the diagnosis, surveillance, and therapy of Barrett's esophagus. Am J Gastroenterol. 1998;93(7):1028.

Winters C, Spurling TJ, Chobanian SJ, Curtis DJ, Esposito RL, Hacker JF, et al. Barrett's esophagus: a prevalent, occult complication of gastroesophageal reflux disease. Gastroenterol. 1987;92(1):118-24.

Csendes A, Smok G, Burdiles P, Korn O, Gradiz M, Rojas J, et al. Prevalence of intestinal metaplasia according to the length of the specialized columnar epithelium lining the distal esophagus in patients with gastroesophageal reflux. Dis Esophagus. 20031;16(1):24-8.

O'Riordan JM, Byrne PJ, Ravi N, Keeling PW, Reynolds JV. Long-term clinical and pathologic response of Barrett's esophagus after antireflux surgery. Am J Surgery. 2004;188(1):27-33.

Salo JA, Salminen JT, Kiviluoto TA, Nemlander AT, Rämö OJ, Färkkilä MA, et al. Treatment of Barrett's esophagus by endoscopic laser ablation and antireflux surgery. Ann Surgery. 1998;227(1):40-4.

Schulz KF, Altman AG, Moher D. Consort 2010 Statement: updated guidelines for reporting parallel group randomised trials. Br Med J. 2010; 340:c332.

Abbas AE, Deschamps C, Cassivi SD, Allen MS, Nichols FC, Miller DL, et al. Barrett's esophagus: the role of laparoscopic fundoplication. Ann Thoracic Surg. 2004;77(2):393-6.

Csendes A, Smok G, Burdiles P, Braghetto I, Henriquez Barrett's esophagus can develop after antireflux surgery Barrett's esophagus after antireflux surgery. Eur Surg. 2008;40 (5): 245-52.

Hofstetter WL, Peters JH, DeMeester TR, Hagen JA, DeMeester SR, Crookes PF, et al. Long-term outcome of antireflux surgery in patients with Barrett’s esophagus. Ann Surg. 2001;234(4):532-9.

Parrilla P, de Haro LF, Ortiz A, Munitiz V, Molina J, Bermejo J, et al. Long-term results of a randomized prospective study comparing medical and surgical treatment of Barrett’s esophagus. Ann Surg. 2003;237(3):291-8.

Rossi M, Barreca M, de Bortoli N, Renzi C, Santi S, Gennai A, et al. Efficacy of Nissen fundoplication versus medical therapy in the regression of low-grade dysplasia in patients with Barrett esophagus: a prospective study. Ann Surg. 2006;243(1):58-63.

DeMeester TR. Surgical therapy for Barrett's esophagus: prevention, protection and excision. Dis Esophagus. 2002;15(2):109-16.

Theisen J, Oberg S. Surgical and medical therapies for GERD. Can we see into the future? Am J Gastroentrol 1998;93(6):1008-9.

Gutschow CA, Schröder W, Prenzel K, Bollschweiler E, Romagnoli R, Collard JM, et al. Impact of antireflux surgery on Barrett's esophagus. Langenbeck's Archiv Surg. 2002;387(3-4):138-45.

Wetscher GJ, Gadenstaetter M, Klingler PJ, Weiss H, Obrist P, Wykypiel H, et al. Efficacy of medical therapy and antireflux surgery to prevent Barrett’s metaplasia in patients with gastroesophageal reflux disease. Ann Surg. 2001;234(5):627-32.






Review Articles